Home›Pomalidomide›Pomalidomide + Elotuzumab

Does Pomalidomide Interact with Elotuzumab?

Pomalidomide and Elotuzumab have a unknown drug interaction according to U.S. FDA drug labeling data. 7 DRUG INTERACTIONS 7.1 Drug Interactions For important drug interactions involving lenalidomide, pomalidomide and dexamethasone, refer to their respective prescribing information. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Unknown
Pomalidomide Class
Thalidomide Analog
Elotuzumab Class
SLAMF7-directed Immunostimulatory Antibody
Management
Consult your pharmacist
Data Source
U.S. FDA via OpenFDA

What To Tell Your Doctor or Pharmacist

If you are taking Pomalidomide and your doctor is considering prescribing Elotuzumab (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Never stop or change either medication without first consulting your healthcare provider
💊 Pomalidomide(Pomalyst)+💊 Elotuzumab(Empliciti)

Severity & Interaction Details

ℹ️
unknown
Interaction documented — severity unclassified
The FDA label notes an interaction but the severity is not classified in our dataset.
Severity scale
MinorContra
On record
Yes
Drug A class
Thalidomide Analog
Drug B class
SLAMF7-directed Immunostimulatory Antibody
Source
FDA drug label - elotuzumab

What this means in plain English

7 DRUG INTERACTIONS 7.1 Drug Interactions For important drug interactions involving lenalidomide, pomalidomide and dexamethasone, refer to their respective prescribing information.

About Pomalidomide and Elotuzumab

Pomalidomide is a Thalidomide Analog, while Elotuzumab is a SLAMF7-directed Immunostimulatory Antibody. You may recognize them by the brand names Pomalyst and Empliciti. Pomalidomide is taken by mouth, whereas Elotuzumab is given by intravenous (IV) infusion. Pomalidomide additionally carries an FDA boxed warning, the FDA's strongest safety alert.

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Pomalidomide and Elotuzumab against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
Data integrity: Every interaction shown is extracted directly from official U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NIH) — no interactions are invented, inferred, or manually edited. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.